Paterson Cancer Center Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 2.09 Cr
as on 04-12-2024
- Company Age 24 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 36.01 Cr
as on 04-12-2024
- Revenue -10.98%
(FY 2020)
- Profit -69.72%
(FY 2020)
- Ebitda -74.26%
(FY 2020)
- Net Worth 0.52%
(FY 2020)
- Total Assets 8.44%
(FY 2020)
About Paterson Cancer Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 2.09 Cr.
The company currently has active open charges totaling ₹36.01 Cr.
Srinivasan Vijayaraghavan, Subramanian Vembu, Manjunath Adiga, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110TN2000PTC045194
- Company No.
045194
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2000
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Paterson Cancer Center?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasan Vijayaraghavan  | Managing Director | 18-May-2001 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subramanian Vembu | Additional Director | 30-Mar-2012 | Current |
| Manjunath Adiga | Director | 28-Nov-2002 | Current |
| Usha Vijayaraghavan | Additional Director | 29-Apr-2023 | Current |
| Srinivasan Krishnan | Additional Director | 11-May-2023 | Current |
Financial Performance of Paterson Cancer Center.
Paterson Cancer Center Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 10.98% decrease. The company also saw a substantial fall in profitability, with a 69.72% decrease in profit. The company's net worth moved up by a moderate rise of 0.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paterson Cancer Center?
In 2020, Paterson Cancer Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medihauxe International India Private LimitedActive 2 years 5 monthsManjunath Adiga is a mutual person
- Oncocare Healthworks & Molecular Engineering Private LimitedActive 5 years 10 months
Usha Vijayaraghavan is a mutual person
- Srinivasan Rajalakshmi Memorial Hospital Private LimitedActive 3 months 18 days
Srinivasan Krishnan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 28 Mar 2012 | ₹33.09 Cr | Open |
Indian Overseas Bank Creation Date: 29 Feb 2008 | ₹2.00 M | Open |
Indian Overseas Bank Creation Date: 01 Nov 2002 | ₹2.72 Cr | Open |
How Many Employees Work at Paterson Cancer Center?
Unlock and access historical data on people associated with Paterson Cancer Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paterson Cancer Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paterson Cancer Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
